Tegoprazan for Prevention of Gastrointestinal Complication in Ischemic Stroke Patients on Antiplatelet Therapy (TegoStroke)
A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 1524 participants.
Also called NCT07687706
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose prevention
- Phase
- Phase 3
- Enrolled
- 1,524 participants
- Sponsor
- Registry
-
NCT07687706
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- South Korea
- Registry status
- Recruiting
Technical summary
Registry record NCT07687706. Randomized; triple masking; primary purpose prevention. Start 2026-01-26 (actual); primary completion 2027-06 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Tegoprazan for Prevention of Gastrointestinal Complication in Ischemic Stroke Patients on Antiplatelet Therapy (TegoStroke)
- Acronym
- TegoStroke
- Condition
- Ischemic Stroke
- Condition
- Ischemic Stroke, Acute
- Condition
- Cerebrovascular Disease
- Condition
- Gastrointestinal Complication
- Condition
- Gastrointestinal Bleeding
- Intervention (Drug)
- Tegoprazan 50 mg
- Intervention (Drug)
- Placebo
- Lead sponsor
- Hanyang University Guri Hospital
- Collaborator
- HK inno.N Corporation
Record details
- Record id
cardio:ct-nct07687706- Content hash
9d065b0b2eb756c5244a7366cfc86ac022b5d6fddab2e94d35705b6b0af41415